Loading patent…
AssigneeInstitut Fur Viruskrankheiten Und Immunprophylaxe
InventorsJon Duri Tratschin, Nicolas Ruggli, Kenneth Charles McCullough
Estimating the term…
The present invention concerns replicons of pestiviruses, in particular replicons of swine fever virus, engineered to have a defective replication thereby having lost infectivity, and further containing a foreign gene. A replicon of the invention contains all the genetic information required for its replication, but lacks essential codons or all codons of at least one of the genes encoding the viral structural proteins E1, E2, Ems or C protein, and consequently cannot generate infectious virus particles. Particular replicons are generated with a mutated gene encoding a modified Npro protein that no longer controls the cell interferon-induction pathway. Another particular replicon lacks the genes encoding all the structural proteins, the p7 protein and the NS2 protein, and has cytopathogenic properties in transduced cells. The replicons of the invention provide a new vector system that can be used for vaccination, gene delivery and gene therapy applications in mammals, including humans, as naked RNA or packaged into any form of delivery vehicle.
A particulate delivery vehicle comprising a single-stranded RNA pestivirus replicon lacking essential codons or all codons for one or more structural proteins required for formation of infectious virus, and carrying a foreign gene, wherein the replicon comprises an NPRO gene that is mutated or C-terminally truncated, the replicon cannot prevent type I IFN induction, and an autoproteolytic activity of the NPRO is maintained, wherein the single-stranded RNA pestivirus replicon is encapsulated inside the particulate delivery vehicle to protect the single-stranded RNA replicon against RNase degradation and wherein the particulate delivery vehicle is appropriate to deliver the single-stranded RNA replicon to the cytoplasm of cells for replication and translation of the single-stranded RNA replicon in the cytoplasm.
A pharmaceutical composition comprising a particulate delivery vehicle comprising a single-stranded RNA pestivirus replicon lacking essential codons or all codons for one or more structural proteins required for formation of infectious virus, and carrying a foreign gene, wherein the replicon comprises an NPRO gene that is mutated or C-terminally truncated, the replicon cannot prevent type I IFN induction, and an autoproteolytic activity of said NPRO is maintained, wherein the single-stranded RNA pestivirus replicon is encapsulated inside the particulate delivery vehicle to protect the single-stranded RNA replicon against RNase degradation and wherein the particulate delivery vehicle is appropriate to deliver the single-stranded RNA replicon to the cytoplasm of cells for replication of the single-stranded RNA replicon in the cytoplasm.
A method of treatment of a disease caused by the lack of a gene, the method comprising the step of administering a particulate delivery vehicle comprising a pestivirus replicon lacking essential codons or all codons for one or more structural proteins required for formation of infectious virus, and carrying a foreign gene, wherein the particulate delivery vehicle is selected from the group consisting of liposomes, microparticles, nanoparticles and nanocapsules, and the foreign gene is the gene that is lacking.
A method of prophylaxis against a disease caused by an infectious agent, the method comprising the step of inducing, in a mammal, an adaptive, humoral immune reaction against the infectious agent by administering a particulate delivery vehicle comprising a single-stranded RNA pestivirus replicon lacking essential codons or all codons for one or more structural proteins required for formation of infectious virus, and carrying a foreign gene, the foreign gene encodes a gene product immunizing against the infectious agent or a disease-causing moiety, wherein the single-stranded RNA pestivirus replicon is encapsulated inside the particulate delivery vehicle to protect the single-stranded RNA replicon against RNase degradation and wherein the particulate delivery vehicle is appropriate to deliver the single-stranded RNA replicon to the cytoplasm of cells for replication and translation of the single-stranded RNA replicon in the cytoplasm.
A pestivirus replicon lacking essential codons or all codons for one or more structural proteins required for formation of infectious virus, and carrying a foreign gene, wherein an Npro gene of the replicon is in a condition selected from the group consisting of mutated and C-terminally truncated, wherein the replicon cannot prevent type I IFN induction, and wherein an autoproteolytic activity of the Npro gene is maintained.
A pestivirus replicon lacking essential codons or all codons for one or more structural proteins required for formation of infectious virus, wherein said replicon retains the ability to replicate in human cells when it is transfected into said human cells, wherein said replicon carries a foreign gene, wherein said replicon comprises an NPRO gene encoding an NPRO protein with maintained autoproteolytic activity, and wherein said foreign gene is inserted within the N-terminal part of said NPRO gene.
A method of prophylaxis against a disease caused by an agent capable of infecting a human subject, the method comprising the step of parenterally administering to the human subject a particulate delivery vehicle comprising a single-stranded RNA classical swine fever virus (CSFV) replicon lacking essential codons or all codons for one or more structural proteins required for formation of infectious virus, and carrying a foreign gene, wherein said replicon is noncytopathogenic and comprises a p7 gene and, wherein the foreign gene encodes a gene product immunizing against the infectious agent, wherein said single-stranded RNA pestivirus replicon is encapsulated inside said particulate delivery vehicle so as to protect said single-stranded RNA CSFV replicon against RNase degradation and wherein said particulate delivery vehicle is appropriate to deliver said single-stranded RNA CSFV replicon to the cytoplasm of cells for replication and translation of said single-stranded RNA CSFV replicon in said cytoplasm.
A method of prophylaxis against a disease caused by an infectious agent capable of infecting a human subject, the method comprising the step of parenterally administering to the human subject a particulate delivery vehicle selected from the group consisting of:
Dependencies are inferred from the claim text.